BlackRock Fund Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

BlackRock Fund Advisors’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$22.8M	Buy	399,298 +48,847	+14%	+$2.96M	﹤0.01%	2108
2016 Q3	$21.8M	Buy	350,451 +17,414	+5%	+$1.23M	﹤0.01%	2027
2016 Q2	$18.8M	Buy	333,037 +127,497	+62%	+$7.75M	﹤0.01%	2057
2016 Q1	$13.2M	Buy	205,540 +19,237	+10%	+$1.56M	﹤0.01%	2223
2015 Q4	$26.2M	Buy	186,303 +147,038	+374%	+$20M	0.01%	1877
2015 Q3	$3.8M	Sell	39,265 -315	-0.8%	-$37.5K	﹤0.01%	2933
2015 Q2	$6M	Buy	+39,580	New	+$6.54M	﹤0.01%	2819

Other funds holding KDNY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return

BlackRock Fund Advisors's KDNY Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Chinook Therapeutics, Inc. Common Stock (KDNY) stake by 14% in Q4 2016, buying an estimated $2.96M and bringing the position to 399,298 shares worth $22.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2108.

BlackRock Fund Advisors first reported a position in KDNY in Q2 2015 and has held it in 7 quarters since. The position peaked at $26.2M in Q4 2015. 87 funds tracked by Wall St. Rank hold KDNY as of Q4 2016.

BlackRock Fund Advisors held 399,298 shares of Chinook Therapeutics, Inc. Common Stock worth $22.8M as of Q4 2016.
BlackRock Fund Advisors bought 48,847 Chinook Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $2.96M.
Chinook Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2108 holding.
BlackRock Fund Advisors first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and has held it in 7 quarters since.
BlackRock Fund Advisors's Chinook Therapeutics, Inc. Common Stock position peaked at $26.2M in Q4 2015.
87 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.